Science and Technology of Nuclear Installations / 2013 / Article / Tab 5

Research Article

Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals

Table 5

RCP of radiopharmaceuticals at and at the expired time specified by the manufacturer, prepared with the first eluate obtained from DRYTEC GE Healthcare generator.

Commercial nameRadiopharmaceuticalRCP ( )RCPex RCP requirements

Neurolite 99mTc-ECD ≥90%
Cardiolite 99mTc-Sestamibi ≥94%
Stamicis 99mTc-Sestamibi ≥94%
Technemibi 99mTc-Sestamibi ≥94%
TechneScan 99mTc-MAG3 ≥95%
Pentacis 99mTc-DTPA ≥95%
Medronato II 99mTc-MDP ≥95%
Osteocis 99mTc-HMDP ≥95%
Nanocoll (PRC = 40 min) 99mTc-nanocolloids ≥95%
Renocis 99mTc-DMSA ≥95%

RCPex indicates the radiochemical purity at the end of the expired time.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.